Table 2 Preoperative serum markers in patients with CBD stones on IOC with and without CBD dilatation on preoperative US
ICO | Patients with stones in CBD | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Preoperative US | CBD <0.8 mm (35 patients) | CBD ≥0.8 mm (49 patients) | |||||||
Normal value | Increased value | Median | Percentiles (25°–75°) | Normal value | Increased value | Median | Percentiles (25°–75°) | P | |
Total bilirubin 3.4–20.5 mmol/L | 9 | 26 | 31.9 | 16.1–69.9 | 8 | 41 | 53.0 | 30.0–88.5 | P > 0.001 |
ALP 40–150 U/L | 20 | 15 | 139.0 | 101.0–193.0 | 20 | 29 | 173.0 | 104.0–280.5 | P > 0.001 |
AST 5–34 U/L | 2 | 33 | 162.0 | 62.0–263.0 | 3 | 46 | 187.0 | 103.5–368.0 | P > 0.001 |
ALT 0–55 U/L | 3 | 32 | 244.0 | 141.0–384.0 | 3 | 46 | 280.0 | 170.0–440.5 | P > 0.001 |
Amylase 30–100 U/L | 0 | 35 | 819.0 | 276.0–2647.0 | 3 | 46 | 1390.0 | 490.0–2283.5 | P > 0.001 |
Lipase 23–300 U/L | 4 | 31 | 1438.0 | 763.0–4899.0 | 8 | 41 | 3563.0 | 974.5–4211.5 | P > 0.001 |